One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 2, 2008, Pages 295-300

  Robertson, Jason O ^a,b   Lober, Cheryl ^a   Smedira, Nicholas G ^a   Navia, Jose L ^a   Sopko, Nikolai ^a   Gonzalez Stawinski, Gonzalo V ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Sepsis; Survival; Transplant; Ventricular assist device

Indexed keywords

ACETYLSALICYLIC ACID; BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; HEPARIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; OKT 3; PREDNISONE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD GROUP O; BRAIN HEMORRHAGE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE; FEMALE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; EPIDEMIOLOGIC METHODS; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSTHESIS-RELATED INFECTIONS;

EID: 46749087797     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.04.027     Document Type: Article

References (22)

1. Bank A.J., Mir S.H., Nguyen D.Q., Bolman III R.M., Shumway S.J., Miller L.W., Kaiser D.R., Ormaza S.M., and Park S.J. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 69 (2000) 1369-1374 [Discussion 1375]
2. Quaini E., Pavie A., Chieco S., and Mambrito B. The concerted action 'Heart' European registry on clinical application of mechanical circulatory support systems: bridge to transplant. The Registry Scientific Committee. Eur J Cardiothorac Surg 11 (1997) 182-188
3. The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients (OPTN/SRTR) Annual Report: Transplant Data 1996-2005; 2006.
4. Sun B.C. Indications for long-term assist device placement as bridge to transplantation. Cardiol Clin 21 (2003) 51-55
5. Gonzalez-Stawinski G.V., Cook D.J., Chang A.S., Banbury M.K., Navia J.L., Hoercher K., Lober C., Atik F.A., Taylor D.O., Yamani M.H., Young J.B., Starling R.C., and Smedira N.G. Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant 25 (2006) 613-618
6. Griffith B.P., Kormos R.L., Nastala C.J., Winowich S., and Pristas J.M. Results of extended bridge to transplantation: window into the future of permanent ventricular assist devices. Ann Thorac Surg 61 (1996) 396-398 [Discussion 407]
7. Gordon S.M., Schmitt S.K., Jacobs M., Smedira N.M., Goormastic M., Banbury M.K., Yeager M., Serkey J., Hoercher K., and McCarthy P.M. Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 72 (2001) 725-730
8. Argenziano M., Catanese K.A., Moazami N., Gardocki M.T., Weinberg A.D., Clavenna M.W., Rose E.A., Scully B.E., Levin H.R., and Oz M.C. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant 16 (1997) 822-831
9. Poston R.S., Husain S., Sorce D., Stanford E., Kusne S., Wagener M., Griffith B.P., and Kormos R.L. LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant 22 (2003) 914-921
10. Ankersmit H.J., Edwards N.M., Schuster M., John R., Kocher A., Rose E.A., Oz M., and Itescu S. Quantitative changes in T-cell populations after left ventricular assist device implantation: relationship to T-cell apoptosis and soluble CD95. Circulation 100 (1999) II211-II215
11. Ankersmit H.J., Tugulea S., Spanier T., Weinberg A.D., Artrip J.H., Burke E.M., Flannery M., Mancini D., Rose E.A., Edwards N.M., Oz M.C., and Itescu S. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet 354 (1999) 550-555
12. Herrmann M., Weyand M., Greshake B., von Eiff C., Proctor R.A., Scheld H.H., and Peters G. Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 95 (1997) 814-817
13. Holman W.L., Murrah C.P., Ferguson E.R., Bourge R.C., McGiffin D.C., and Kirklin J.K. Infections during extended circulatory support: University of Alabama at Birmingham experience 1989 to 1994. Ann Thorac Surg 61 (1996) 366-371 [Discussion 372-363]
14. McCarthy P.M., Schmitt S.K., Vargo R.L., Gordon S., Keys T.F., and Hobbs R.E. Implantable LVAD infections: implications for permanent use of the device. Ann Thorac Surg 61 (1996) 359-365 [Discussion 372-353]
15. Vilchez R.A., McEllistrem M.C., Harrison L.H., McCurry K.R., Kormos R.L., and Kusne S. Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support. Ann Thorac Surg 72 (2001) 96-101
16. Sinha P., Chen J.M., Flannery M., Scully B.E., Oz M.C., and Edwards N.M. Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 102 (2000) III194-III199
17. Joyce D.L., Southard R.E., Torre-Amione G., Noon G.P., Land G.A., and Loebe M. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant 24 (2005) 2054-2059
18. Pagani F.D., Dyke D.B., Wright S., Cody R., and Aaronson K.D. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival. J Heart Lung Transplant 20 (2001) 646-653
19. Pamboukian S.V., Costanzo M.R., Dunlap S., Rayburn B., Westfall A.O., You Z.Y., Hung E., McLeod M., and Heroux A. Relationship between bridging with ventricular assist device on rejection after heart transplantation. J Heart Lung Transplant 24 (2005) 310-315
20. Radovancevic B., Golino A., Vrtovec B., Thomas C.D., Radovancevic R., Odegaard P., van Rossem C.C., Gaemers S.J., Vaughn W.K., Smart F.W., and Frazier O.H. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?. J Heart Lung Transplant 24 (2005) 703-707
21. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96 (1997) 2069-2077
22. Gonzalez-Stawinski G.V., Cook D.J., Chang A.S., Atik F., Navia J.L., Banbury M., Roselli E., Young J.B., Starling R.A., and Smedira N.G. Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices. Transplantation 79 (2005) 1175-1179